Chemokine CXCL10
-
Subject Areas on Research
- A comparison of host response strategies to distinguish bacterial and viral infection.
- An Atlas of Genetic Variation Linking Pathogen-Induced Cellular Traits to Human Disease.
- Anti-angiogenic effects of interleukin-12 delivered by a novel hyperthermia induced gene construct.
- Biomarkers for kidney transplant rejection.
- CXCL10 is upregulated in synovium and cartilage following articular fracture.
- CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease.
- Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B.
- Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study.
- Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study.
- Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant.
- Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge.
- Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction.
- Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group.
- Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
- Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration.
- Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma.
- Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
- Long-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation.
- MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
- Modeling of variables in cellular infection reveals CXCL10 levels are regulated by human genetic variation and the Chlamydia-encoded CPAF protease.
- Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine.
- Pathogen Evasion of Chemokine Response Through Suppression of CXCL10.
- Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.
- Protective immunity in recurrent Staphylococcus aureus infection reflects localized immune signatures and macrophage-conferred memory.
- RNA-Seq and ChIP-Seq reveal SQSTM1/p62 as a key mediator of JunB suppression of NF-κB-dependent inflammation.
- Recruited exudative macrophages selectively produce CXCL10 after noninfectious lung injury.
- Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage.
- Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine.
- The CXCL10/CXCR3 Axis Promotes Disease Pathogenesis in Mice upon CVA2 Infection.
- Tumor necrosis factor-α pathway plays a critical role in regulating interferon-γ induced protein-10 production in initial allogeneic human monocyte-endothelial cell interactions.
- Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection.
- Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.
- Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
- Variation in Leishmania chemokine suppression driven by diversification of the GP63 virulence factor.